Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Fentanyl Citrate.

Client Email

Product

Fentanyl Citrate
Droperidol
CAS 1474-02-8
CAS 21409-26-7
Sufentanil Citrate
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Veranova Fentanyl Citrate

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Fentanyl Citrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 14 USDMF, 12 CEP/COS, 3 JDMF, 3 EU WC, 4 KDMF, 16 NDC API, 17 Listed Suppliers, $ API Reference Price

32 API Suppliers
14 USDMF
12 CEP/COS
3 JDMF
3 EU WC
4 KDMF
16 NDC API
17 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

API Reference Price
API Exports
API Imports
FDF Exports

FINISHED DOSAGE FORMULATIONS

279 FDF Dossiers, 77 FDA Orange Book, 159 Europe, 14 Canada, 3 South Africa, 26 Listed Dossiers

279 FDF Dossiers
77 FDA Orange Book
159 Europe
14 Canada
3 South Africa
26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE, TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE
TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 1 Jai Radhe Sales, 2 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 34 Direct Compression, 28 Disintegrants & Superdisintegrants, 23 Controlled & Modified Release, 18 Thickeners and Stabilizers, 17 Taste Masking, 16 Granulation, 15 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 11 Lubricants & Glidants, 11 Film Formers & Plasticizers, 9 Parenteral, 5 Solubilizers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Topical, 3 Rheology Modifiers, 2 Coloring Agents

59 Fillers, Diluents & Binders
42 Coating Systems & Additives
34 Direct Compression
28 Disintegrants & Superdisintegrants
23 Controlled & Modified Release
18 Thickeners and Stabilizers
17 Taste Masking
16 Granulation
15 Chewable & Orodispersible Aids
14 Co-Processed Excipients
11 Lubricants & Glidants
11 Film Formers & Plasticizers
9 Parenteral
5 Solubilizers
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
3 Emulsifying Agents
3 Topical
3 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 35 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 103 Finished Drug Prices

2 US Medicaid Prescriptions
103 Finished Drug Prices

MARKET PLACE

11 APIs, 5 FDF Dossiers

11 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 17 Health Canada Patents

36 US Patents
17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

2 EDQM
1 USP
3 Others

$ API Ref.Price (USD/KG) : 64,860 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

17 All

01 1Gowling Lafleur Henderson LLP

02 1Gowling Lafleur Henderson LLP

03 15Teva Canada Innovation

filter Patent Reset all filters

17 All

01 52333375

02 22417727

03 52548915

04 52569674

filter Product Reset all filters

17 All

01 17Fentanyl Citrate

filter Dosage Reset all filters

17 All

01 2Aqueous solution

02 12Tablet

03 3Tablets

filter Exp Date Reset all filters

17 All

01 102020-03-22

02 22021-07-31

03 52024-12-30

Aspen Fentanyl Citrate

US Patents
Health Canada Patents

Product Main Page

01

Gowling Lafleur Henderson LLP

Fentanyl Citrate

Luxepack

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-07-31

Date Granted : 2009-09-01

Fentanyl Citrate

Brand Name : INSTANYL

Patent Number : 2417727

Filing Date : 2001-07-31

Strength per Unit : 100 mcg

Dosage Form : Aqueous solution

Human Or VET : Human

Route of Administration : Nasal

Patent Expiration Date : 2021-07-31

Date Granted : 2009-09-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Fentanyl Citrate

Luxepack

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-07-31

Date Granted : 2009-09-01

Fentanyl Citrate

Brand Name : INSTANYL

Patent Number : 2417727

Filing Date : 2001-07-31

Strength per Unit : 200 mcg

Dosage Form : Aqueous solution

Human Or VET : Human

Route of Administration : Nasal

Patent Expiration Date : 2021-07-31

Date Granted : 2009-09-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Teva Canada Innovation

Fentanyl Citrate

Luxepack

Not Confirmed

Teva Canada Innovation

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-03-22

Date Granted : 2011-11-08

Fentanyl Citrate

Brand Name : FENTORA

Patent Number : 2569674

Filing Date : 2000-03-22

Strength per Unit : 100 mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-03-22

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Teva Canada Innovation

Fentanyl Citrate

Luxepack

Not Confirmed

Teva Canada Innovation

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-12-30

Date Granted : 2012-10-16

Fentanyl Citrate

Brand Name : FENTORA

Patent Number : 2548915

Filing Date : 2004-12-30

Strength per Unit : 100 mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-12-30

Date Granted : 2012-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Teva Canada Innovation

Fentanyl Citrate

Luxepack

Not Confirmed

Teva Canada Innovation

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-03-22

Date Granted : 2007-05-29

Fentanyl Citrate

Brand Name : FENTORA

Patent Number : 2333375

Filing Date : 2000-03-22

Strength per Unit : 100 mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-03-22

Date Granted : 2007-05-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Teva Canada Innovation

Fentanyl Citrate

Luxepack

Not Confirmed

Teva Canada Innovation

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-03-22

Date Granted : 2011-11-08

Fentanyl Citrate

Brand Name : FENTORA

Patent Number : 2569674

Filing Date : 2000-03-22

Strength per Unit : 200 mcg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-03-22

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Teva Canada Innovation

Fentanyl Citrate

Luxepack

Not Confirmed

Teva Canada Innovation

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-12-30

Date Granted : 2012-10-16

Fentanyl Citrate

Brand Name : FENTORA

Patent Number : 2548915

Filing Date : 2004-12-30

Strength per Unit : 200 mcg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-12-30

Date Granted : 2012-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Teva Canada Innovation

Fentanyl Citrate

Luxepack

Not Confirmed

Teva Canada Innovation

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-03-22

Date Granted : 2007-05-29

Fentanyl Citrate

Brand Name : FENTORA

Patent Number : 2333375

Filing Date : 2000-03-22

Strength per Unit : 200 mcg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-03-22

Date Granted : 2007-05-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Teva Canada Innovation

Fentanyl Citrate

Luxepack

Not Confirmed

Teva Canada Innovation

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-03-22

Date Granted : 2011-11-08

Fentanyl Citrate

Brand Name : FENTORA

Patent Number : 2569674

Filing Date : 2000-03-22

Strength per Unit : 400 mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-03-22

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Teva Canada Innovation

Fentanyl Citrate

Luxepack

Not Confirmed

Teva Canada Innovation

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-12-30

Date Granted : 2012-10-16

Fentanyl Citrate

Brand Name : FENTORA

Patent Number : 2548915

Filing Date : 2004-12-30

Strength per Unit : 400 mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-12-30

Date Granted : 2012-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?